A transmissible agent, the IM virus, antigenically related to the Japanese subacute myelo-optico-neuropathy virus, has been isolated from several human cerebrospinal fluids obtained from American patients with multiple sclerosis and other chronic diseases of the central nervous system. The isolates were propagated in human diploid fibroblast (MRC5) cells, and virus was released into the culture medium in Recently, we reported the isolation of a virus from the cerebrospinal fluid (CSF) of three Texan patients with multiple sclerosis (MS) and one patient with amyotrophic lateral sclerosis (8). Since then, we have recovered a number of additional American isolates, chiefly from patients with MS but also from patients with other chronic central nervous system diseases. The isolates proved to be antigenically related to a virus recovered in Japan from the CSF of patients with subacute myelo-optico-neuropathy (SMON) (5, 6, 9) . The virus has also been reported previously from an American who died of a disease presenting the characteristics of SMON (1). However, until its clinical spectrum is more fully understood, Inoue et al. (5) We present here our findings on the characteristics of the new viral isolates. The isolates have been difficult to work with because of the mildness of the changes produced in the host cells in culture. To establish reproducible and reliable viral titrations, we found it necessary to carry them out under code, tedious as this might be. Since all the isolates showed antigenic relationships but not identity (5), we selected one (Baylor isolate no. 9) for detailed investigation. However, many of the tests described below for isolate no. 9 were also run with other isolates and the results were similar. Therefore, only the results with isolate no. 9 are presented. supplemented with 10% fetal bovine serum (FBS; GIBCO), 0.07% sodium bicarbonate, penicillin (100 U/ml), and streptomycin (100 ,ug/ml).
Recently, we reported the isolation of a virus from the cerebrospinal fluid (CSF) of three Texan patients with multiple sclerosis (MS) and one patient with amyotrophic lateral sclerosis (8) . Since then, we have recovered a number of additional American isolates, chiefly from patients with MS but also from patients with other chronic central nervous system diseases. The isolates proved to be antigenically related to a virus recovered in Japan from the CSF of patients with subacute myelo-optico-neuropathy (SMON) (5, 6, 9) . The virus has also been reported previously from an American who died of a disease presenting the characteristics of SMON (1) . However, until its clinical spectrum is more fully understood, Inoue et al. (5) have suggested that the virus be called IM virus (IMV) .
We present here our findings on the characteristics of the new viral isolates. The isolates have been difficult to work with because of the mildness of the changes produced in the host cells in culture. To establish reproducible and reliable viral titrations, we found it necessary to carry them out under code, tedious as this might be. Since all the isolates showed antigenic relationships but not identity (5), we selected one (Baylor isolate no. 9) for detailed investigation. However, many of the tests described below for isolate no. 9 were also run with other isolates and the results were similar. Therefore, only the results with isolate no. 9 are presented.
MATERIALS AND METHODS
Cell culture. MRC5 human diploid fibroblasts were obtained from Flow Laboratories, Inc., (McLean, Va.) and cultured as previously described (8) . Cell cultures between passages number 30 and 38 yielded the best results in viral titrations. Cells were cultured at 37°C in Eagle basal medium with Earle salts (GIBCO Laboratories, Grand Island, N.Y.) supplemented with 10% fetal bovine serum (FBS; GIBCO), 0.07% sodium bicarbonate, penicillin (100 U/ml), and streptomycin (100 ,ug/ml).
Virus culture. The virus isolates studied in this report were obtained from the CSF of patients with MS (8) . Stocks of the virus isolates were prepared by infecting MRC5 cells cultured in 75-cm2 plastic flasks (Corning Glass Works, Corning, N.Y.) with a multiplicity of infection of ca. 0.01 50% tissue culture infective doses (TCD50) per cell. Infected cultures were maintained in Eagle minimal essential medium (MEM; GIBCO) supplemented with 2% inactivated FBS, 0.1% sodium bicarbonate, and antibiotics. Cell-free culture fluids were collected 6 days postinfection and were clarified at 3,000 x g for 10 min. The TCD50 was calculated by the method of Reed and Muench (10) .
To achieve consistency, it was essential to eliminate observer bias. This was done as follows. The experiment was set up, and the virus was distributed in test tubes in conventional fashion ready for inoculation of the cell cultures. Then the tubes were randomly coded by another person, and the code was placed in a sealed envelope. After the scoring of cellular changes in the coded cultures by at least two observers was completed on days 5 with Sybron Nalge (pore diameter, 450 and 200 nm) and Millipore (pore diameter, 100 and 50 nm) nitrocellulose membrane filters. The filters were sterilized with UV light. All filters were pretreated with MEM containing 2% FBS to reduce nonspecific adsorption of the virus. Virus isolate no. 9 was diluted 10-fold in MEM containing 2% FBS. A sample for titration was taken before passage through the filters.
Samples of the diluted virus were passed through a 450-, 200-, and 100-, or 50-nm filter and titrated for infectivity. In addition to poliovirus and herpes simplex virus, SMON virus (6) served as a control.
Differential centrifugation. Ultracentrifugations were performed in a Beckman L5-50 ultracentrifuge with a type 75 Ti rotor. Isolate no. 9 was diluted 10-fold with MEM containing 2% FBS. Samples were subjected to centrifugation at a speed and time sufficient to generate the desired centrifugal force. The relative centrifugal force (RCF) was calculated by the formula RCF = rw2/980, and the approximate sedimentation value (S) of the pellet was determined by the equation S = kit (4) . The supernatants were removed carefully and saved for titration. The pellets were resuspended in 1 ml of MEM containing 2% FBS by vortexing and sonication and were saved for titration. Titration of isolate no. 9 was performed as described above. Poliovirus and simian papovavirus simian virus 40 served as controls. cellular contact, and some cells became swollen and granulated. Figures 1 and 2 show stained preparations of uninfected and infected cell cultures at low and high magnifications. The virus-induced changes were subtle; coded titrations were always done, and the results were dependent upon close comparisons to mock-infected cell controls.
Influence of cell passage level. As we gained experience with the virus-cell system, we observed that the cytopathic changes were (Fig. 3) . The titer of released virus increased another 100 times by 48 h, when the supernatant fluids contained 106 TCD50 of virus per ml. In summary, the first infectious progeny were released into the The properties that we have found are consistent with those reported earlier by Nishibe et al. (9) . The agent is a medium-sized virus, contains essential lipid, and requires DNA for its replication. The estimated size (about 100 nm in diameter) and sedimentation coefficient (over 158S but less than 500S) of the virus suggest that it is in the middle of the viral range. The ether sensitivity of virus infectivity and the presence of virus in the culture medium in the absence of cytolysis suggest that the virus may acquire an envelope by budding through the plasma membrane. Replicating DNA is necessary for viral replication; however, our many attempts at electron microscopic examination of the infected cells or of virus concentrated by ultracentrifugation have failed to reveal recognizable virus particles. Furthermore, numerous attempts to identify the virus by radiolabeling have been unsuccessful. We would be tempted to think of a scrapie-like membranous agent (7), except for the much larger size of our virus.
As of this writing, three antigenic types of the virus have been recognized (5) . To avoid any connotation that there is evidence of an etiological relationship of this virus to any specific disease in the American patients, the agent is being temporarily designated as the IM virus (5), with the term SMON reserved only for the strains which had been isolated from the Japanese patients with SMON (6).
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